Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period von Ward, Leanne M, Högler, Wolfgang, Glorieux, Francis H, Portale, Anthony A, Whyte, Michael P, Munns, Craig F, Nilsson, Ola, Simmons, Jill H, Padidela, Raja, Namba, Noriyuki, Cheong, Hae Il, Sochett, Etienne, Muroya, Koji, Tanaka, Hiroyuki, Pitukcheewanont, Pisit, Gottesman, Gary S, Biggin, Andrew, Perwad, Farzana, Chen, Angel, Lawrence Merritt Ii, John, Imel, Erik A

Volltext

Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening von Merritt, J. Lawrence, Vedal, Sverre, Abdenur, Jose E., Au, Sylvia M., Barshop, Bruce A., Feuchtbaum, Lisa, Harding, Cary O., Hermerath, Cheryl, Lorey, Fred, Sesser, David E., Thompson, John D., Yu, Arthur

Volltext